Christian Macks1, Daun Jeong1, Jeoung Soo Lee1. 1. Department of Bioengineering, Drug Design, Development, & Delivery (4D) Laboratory, Clemson University, Clemson, SC 29634, USA.
Abstract
Aim: To develop poly(lactide-co-glycolide)-graft-polyethylenimine (PgP) as a nanocarrier for the delivery of rolipram (Rm) and evaluate the therapeutic efficacy of Rm-loaded PgP (Rm-PgP) on secondary injury and motor function in a rat traumatic brain injury (TBI) model. Materials & methods: Rm-PgP was injected in the injured brain lesion immediately after TBI using a microinjection pump. Secondary injury pathologies such as inflammatory response, apoptosis and astrogliosis were assessed by histological analysis and functional recovery was assessed by assorted motor function tests. Results: Rm-PgP restored cyclic adenosine monophosphate level in the injured brain close to the sham level and Rm-PgP treatment reduced lesion volume, neuroinflammation and apoptosis and improved motor function at 7 days post-TBI. Conclusion: One single injection of Rm-PgP can be effective for acute mild TBI treatment.
Aim: To develop poly(lactide-co-glycolide)-graft-polyethylenimine (PgP) as a nanocarrier for the delivery of rolipram (Rm) and evaluate the therapeutic efficacy of Rm-loaded PgP (Rm-PgP) on secondary injury and motor function in a rat traumatic brain injury (TBI) model. Materials & methods: Rm-PgP was injected in the injured brain lesion immediately after TBI using a microinjection pump. Secondary injury pathologies such as inflammatory response, apoptosis and astrogliosis were assessed by histological analysis and functional recovery was assessed by assorted motor function tests. Results: Rm-PgP restored cyclic adenosine monophosphate level in the injured brain close to the sham level and Rm-PgP treatment reduced lesion volume, neuroinflammation and apoptosis and improved motor function at 7 days post-TBI. Conclusion: One single injection of Rm-PgP can be effective for acute mild TBI treatment.
Authors: Anthony A Oliva; Yuan Kang; Concepcion Furones; Ofelia F Alonso; Olga Bruno; W Dalton Dietrich; Coleen M Atkins Journal: J Neurochem Date: 2012-11-01 Impact factor: 5.372
Authors: A Lamprecht; N Ubrich; H Yamamoto; U Schäfer; H Takeuchi; C M Lehr; P Maincent; Y Kawashima Journal: J Control Release Date: 2001-04-28 Impact factor: 9.776
Authors: Damien D Pearse; Francisco C Pereira; Alexander E Marcillo; Margaret L Bates; Yerko A Berrocal; Marie T Filbin; Mary Bartlett Bunge Journal: Nat Med Date: 2004-05-23 Impact factor: 53.440
Authors: Jean-Denis Troadec; Marc Marien; Sophie Mourlevat; Thomas Debeir; Merle Ruberg; Francis Colpaert; Patrick P Michel Journal: Mol Pharmacol Date: 2002-11 Impact factor: 4.436
Authors: Martha I Betancur; Hannah D Mason; Melissa Alvarado-Velez; Phillip V Holmes; Ravi V Bellamkonda; Lohitash Karumbaiah Journal: ACS Biomater Sci Eng Date: 2017-02-13